ReviewJournal of general and family medicine2019

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Masayuki Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.